Oppenheimer & Co. Inc. Has $2.82 Million Holdings in The Clorox Company (NYSE:CLX)

Oppenheimer & Co. Inc. grew its position in The Clorox Company (NYSE:CLX) by 1.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,310 shares of the company’s stock after purchasing an additional 268 shares during the period. Oppenheimer & Co. Inc.’s holdings in Clorox were worth $2,820,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Empower Advisory Group LLC lifted its position in shares of Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after buying an additional 78 shares during the last quarter. Victory Capital Management Inc. raised its stake in Clorox by 45.0% in the 3rd quarter. Victory Capital Management Inc. now owns 323,612 shares of the company’s stock worth $52,720,000 after purchasing an additional 100,453 shares in the last quarter. Ashton Thomas Private Wealth LLC boosted its holdings in Clorox by 3.9% in the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 6,738 shares of the company’s stock valued at $1,098,000 after purchasing an additional 254 shares during the period. Platform Technology Partners grew its position in shares of Clorox by 3.4% during the 3rd quarter. Platform Technology Partners now owns 7,230 shares of the company’s stock worth $1,178,000 after purchasing an additional 238 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its stake in Clorox by 2.0% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 307,649 shares of the company’s stock worth $50,119,000 after acquiring an additional 6,008 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CLX has been the topic of several analyst reports. DA Davidson increased their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Citigroup boosted their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. JPMorgan Chase & Co. raised their target price on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their price objective for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $155.00.

Clorox Trading Up 1.1 %

CLX opened at $167.64 on Friday. The company has a market cap of $20.75 billion, a P/E ratio of 58.41, a price-to-earnings-growth ratio of 3.06 and a beta of 0.41. The company has a fifty day moving average price of $162.45 and a two-hundred day moving average price of $147.47. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $169.09.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 earnings per share. The company’s quarterly revenue was up 27.0% on a year-over-year basis. Analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.91%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio is 170.04%.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.